Affiliated Researchers

ICER is proud to work with renown academics in the fields of clinical evidence synthesis and economic modeling. Here is a selection of the experts that we routinely collaborate with to develop our reports:

Clinical Synthesis

  • Grace Lin, MD, Medical Director, Health Technology Assessment, ICER, Professor of Medicine, University of California, San Francisco
  • Jeffrey A. Tice, MD, Professor of Medicine, University of California, San Francisco
  • Anil Makim, MD, MAS, Associate Professor in Residence and Director of Analytics & Research, University of California, San Francisco
  • Jason Wasfy, MD, MPhil, Associate Professor, Harvard Medical School, Director of Outcomes Research, Massachusetts General Hospital

    Economic Modeling

    • Josh Carlson, PhD, MPH, Professor & Graduate Program Director, CHOICE Institute, University of Washington
    • Michael Distefano, PhD, MBE, Assistant Professor, University of Colorado Anshutz Medical Campus
    • Kibum Kim, PhD, MSc, BPharm, Assistant Professor at College of Pharmacy, Pharmacy Systems, Outcomes, and Policy, University of Illinois Chicago
    • Linda Luu, MSc, Research Scientist, University of Washington
    • R. Brett McQueen, PhD, Associate Professor, University of Colorado Anshutz Medical Campus
    • Kangho Suh, PharmD, PhD, Assistant Professor, School of Pharmacy, University of Pittsburgh
    • Surrey Walton, PhD, MA, Professor, College of Pharmacy-Pharmacy Systems Outcomes and Policy, Assistant Director, Center for Pharmaco Epidemiology and Pharmacoeconomic Research, University of Illinois Chicago
    • Aaron Winn, PhD, MPP, Associate Professor, University of Illinois Chicago
    • Antal Zemplenyi, PhD, Research Assistant Professor, University of Colorado Anshutz Medical Campus

      ICER Advisors

      • Surya Singh, MD, President & Owner, Singh Healthcare Advisors, LLC and Adjunct Instructor of Medicine, Harvard Medical School (Profile)

      Technology Partner for ICER Analytics’ Interactive Modeler

      • Oleksandr Topachevskyi, PGDip, Founder & Health Economist, Digital Health Outcomes (Profile)

      Health Economics Council

      To ensure that all reports incorporate the most up-to-date methods and best practices in health economics, ICER collaborates with an academic council of experts, leveraging their expertise to support ICER’s work in assessing drugs and other interventions. Currently, ICER’s health economics partners include:

      The University of Washington School of Pharmacy’s Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute

      The CHOICE Institute conducts research and provides graduate and external training in health outcomes and policy research on health care technologies, with a focus on drugs, diagnostics, and devices. The overall goal of the program is to generate evidence that improves health care decisions for patients, clinicians, payers, industry and government organizations. The CHOICE Institute is a nationally and internationally recognized center for pharmaceutical economics, drug safety, and pharmaceutical policy research. Read more about this collaboration here. 

      The University of Colorado’s Skaggs School of Pharmacy and Pharmaceutical Sciences’ Center for Pharmaceutical Outcomes Research (CePOR)

      The major goal of CePOR is to promote training and interdisciplinary research collaborations in the areas of pharmacoeconomics, health services and systems research, drug policy, health benefits design, pharmacoepidemiology, and drug safety. Read more about this collaboration here.

      The University of Illinois at Chicago College of Pharmacy’s Center for Pharmacoepidemiology and Pharmacoeconomic Research (CPR)

      The goal of the Center is to advance understanding of the impact of pharmacy and health care services, products, and policy by conducting research in pharmacoeconomics, pharmacoepidemiology, and patient-centered outcomes; translating and disseminating research; and educating, training, and mentoring researchers. Read more about this collaboration here.